Skip to content
healthcare.dev

Levetiracetam

NDC 68180-117, Levetiracetam, tablet, extended release, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-117
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091399
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM500 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
68180-117-076818001170760 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-117-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/18648f51-a37c-41e1-b451-123bc0cf5446
  • NADAC price for package 68180011707

    GET /v1/drugs/nadac/68180011707

Use it

Look up 68180-117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.